CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.
Schroeder BA, LaFranzo NA, LaFleur BJ, Gittelman RM, Vignali M, Zhang S, Flanagan KC, Rytlewski J, Riolobos L, Schulte BC, Kim TS, Chen E, Smythe KS, Wagner MJ, Mantilla JG, Campbell JS, Pierce RH, Jones RL, Cranmer LD, Pollack SM.
Schroeder BA, et al. Among authors: rytlewski j.
J Immunother Cancer. 2021 Aug;9(8):e002812. doi: 10.1136/jitc-2021-002812.
J Immunother Cancer. 2021.
PMID: 34465597
Free PMC article.